Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
API
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Lacidipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lacidipine, including repackagers and relabelers. The FDA regulates Lacidipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lacidipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lacidipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lacidipine supplier is an individual or a company that provides Lacidipine active pharmaceutical ingredient (API) or Lacidipine finished formulations upon request. The Lacidipine suppliers may include Lacidipine API manufacturers, exporters, distributors and traders.
click here to find a list of Lacidipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lacidipine DMF (Drug Master File) is a document detailing the whole manufacturing process of Lacidipine active pharmaceutical ingredient (API) in detail. Different forms of Lacidipine DMFs exist exist since differing nations have different regulations, such as Lacidipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lacidipine DMF submitted to regulatory agencies in the US is known as a USDMF. Lacidipine USDMF includes data on Lacidipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lacidipine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lacidipine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lacidipine Drug Master File in Korea (Lacidipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lacidipine. The MFDS reviews the Lacidipine KDMF as part of the drug registration process and uses the information provided in the Lacidipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lacidipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lacidipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lacidipine suppliers with KDMF on PharmaCompass.
A Lacidipine written confirmation (Lacidipine WC) is an official document issued by a regulatory agency to a Lacidipine manufacturer, verifying that the manufacturing facility of a Lacidipine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lacidipine APIs or Lacidipine finished pharmaceutical products to another nation, regulatory agencies frequently require a Lacidipine WC (written confirmation) as part of the regulatory process.
click here to find a list of Lacidipine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lacidipine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lacidipine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lacidipine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lacidipine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lacidipine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lacidipine suppliers with NDC on PharmaCompass.
Lacidipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lacidipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lacidipine GMP manufacturer or Lacidipine GMP API supplier for your needs.
A Lacidipine CoA (Certificate of Analysis) is a formal document that attests to Lacidipine's compliance with Lacidipine specifications and serves as a tool for batch-level quality control.
Lacidipine CoA mostly includes findings from lab analyses of a specific batch. For each Lacidipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lacidipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Lacidipine EP), Lacidipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lacidipine USP).
LOOKING FOR A SUPPLIER?
